Intas Pharmaceuticals Ltd. (biopharma Division) - Employees, Business, Industry & CEO


Intas Pharmaceuticals Ltd. (biopharma Division) Frequently Asked Questions

When was Intas Pharmaceuticals Ltd. (biopharma Division) founded?

Intas Pharmaceuticals Ltd. (biopharma Division) was founded in 2000.

Who is the Founder of Intas Pharmaceuticals Ltd. (biopharma Division)?

Binish Chudgar is the founder of Intas Pharmaceuticals Ltd. (biopharma Division).

Where are Intas Pharmaceuticals Ltd. (biopharma Division) headquarters?

Intas Pharmaceuticals Ltd. (biopharma Division) headquarters are in Ahmedabad, Gujarat, India.

How many employees does Intas Pharmaceuticals Ltd. (biopharma Division) have?

Intas Pharmaceuticals Ltd. (biopharma Division) has 1313 employees.

What sector does Intas Pharmaceuticals Ltd. (biopharma Division) operate in?

Intas Pharmaceuticals Ltd. (biopharma Division) is in biotechnology, pharmaceuticals sector.

Is Intas Pharmaceuticals Ltd. (biopharma Division) a private company?

Yes, Intas Pharmaceuticals Ltd. (biopharma Division) is a private company.

What does Intas Pharmaceuticals Ltd. (biopharma Division) Do ?

Our mission: develop, manufacture and license, quality and affordable medicines for billions of people across the world. intas pharmaceuticals is one of the fastest growing generic pharmaceutical companies, with an extensive presence in india, us, america, europe and rest of the world including asia. we have a robust product portfolio in vital therapeutic areas, such as oncology, cardiology, neurology, nephrology, urology, psychiatry, diabetology, pain management and gastroenterology and over 5500 product approvals (as of april, 2016) in various markets. our sales, marketing and distribution network now reaches over 70 countries. our products are approved by major global regulatory agencies such as the usfda, uk mhra, ema, tga, mcc, anvisa and others. intas operates in north america and europe as accord healthcare with a strategic vision to create a global branding in the world’s largest pharmaceutical markets. through a strong commercial infrastructure we have brought high quality yet affordable products to patients all over the world. biopharma division of intas was created in the year 2000 with a mission to provide affordable “biosimilars for billions” across niche segments such as oncology, auto-immune, ophthalmology, nephrology, rheumatology, and hormone based therapies. intas biopharma is now a leading biosimilar company in india with as many as 14 products approved by dcgi (govt. of india). our biosimilar products are registered in more than 22 countries, and are under registration in more than 25 countries, through strategic marketing alliances. the biopharma division of intas is a fully integrated biotech arm located at ahmedabad, india housing product development, manufacturing and commercial operations functions working in tandem. the product development comprises of two major groups - early stage development and the late stage development. the manufacturing and commercial operations comprises of - bio bulk manufacturing & fill-finish facilities, quality assurance & regulatory teams and quality control laboratories. the bulk manufacturing facility houses several fermenters for microbial products ranging from 50 to 150 liters and bioreactors ranging from 150 to 4000 liters for several mammalian cell culture based products. it also has a dedicated and automated pre-filled syringes, vials and cartridges filling machines for all biosimilar products produced at site. in 2013, our biopharma division received eu-gmp approval for its gcsf biosimilar paving its entry to eu market. we recently launched (in 2018) peg-gcsf in eu market and we now have two biosimilars in eu market. biopharma division has over 900 employees, many of whom are scientists and bioprocess engineers, working on a very strong pipeline of products and over the next few years biopharma division will launch products in geographies such as us. key highlights among the top 10 pharma companies in india with cagr of ~25%. highest number of biosimilars - 14 products approved in india in various therapeutic areas 1st indian company to get approval for marketing of filgrastim in europe and canada. 1st indian company to get approval and launch of pegfilgrastim in europe and canada 1st company to launch biosimilar ranibizumab and denosumab in india 2nd company to launch rituximab in india

What does Intas Pharmaceuticals Ltd. (biopharma Division) specialize into ?

Intas Pharmaceuticals Ltd. (biopharma Division) specialises into Biosimilars Development, Recombinant Proteins Manufacturing

Who is the CEO of Intas Pharmaceuticals Ltd. (biopharma Division) ?

Binish Chudgar

Intas Pharmaceuticals Ltd. (biopharma Division)- Phone & Email of Top Employees & Directors


Jayesh Brahmbhatt

Senior Vice President at Intas Pharmaceuticals Ltd. (biopharma Division)

Ahmedabad Area, India
jxxx@intaspharma.com
98981*****
Deven Mhatre

Head Hr - Emerging Markets at Intas Pharmaceuticals Ltd. (biopharma Division)

India
dxxx@intaspharma.com
98905*****

The most accurate data ever

GDPR Compliant
150M Personal Emails
200M Work Emails
100M Direct Dials
250M Professional Profiles
30M Company Profiles